Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Study

Lang G. E., Berta A., Eldem B. M., Simader C., Sharp D., Holz F. G., ...More

OPHTHALMOLOGY, vol.120, no.10, pp.2004-2012, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 120 Issue: 10
  • Publication Date: 2013
  • Doi Number: 10.1016/j.ophtha.2013.02.019
  • Journal Name: OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.2004-2012
  • Hacettepe University Affiliated: Yes


Objective: To evaluate the 2-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema (DME).